Drug · DIN 02374641
IPG-SIMVASTATIN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since January 7, 2016.
- Drug Identification Number (DIN)
- 02374641
- Company (DIN owner)
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Simvastatin C10AA01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SIMVASTATIN | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 7, 2015: NOC 17651Abbreviated New Drug Submission (ANDS) · Merger - buyout
- September 30, 2011: NOC 12671Abbreviated New Drug Submission (ANDS)
Other DINs named IPG-SIMVASTATIN
- DIN 02374625 · Approved
- DIN 02374633 · Approved
- DIN 02374668 · Approved
- DIN 02374676 · Approved